elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36777115-6A6A4758-725E-4154-89C7-5F3289B2CD53
Q36777115-6A6A4758-725E-4154-89C7-5F3289B2CD53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36777115-6A6A4758-725E-4154-89C7-5F3289B2CD53
Synthesis of novel analogs of cabergoline: improving cardiovascular safety by removing 5-HT2B receptor agonism.
P2860
Q36777115-6A6A4758-725E-4154-89C7-5F3289B2CD53
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36777115-6A6A4758-725E-4154-89C7-5F3289B2CD53
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
63b11ee175d44217e2b96daaed0f946c318a5aa4
P2860
Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis